Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Imagin Medical Inc C.IME

Alternate Symbol(s):  IMEXF

Imagin Medical Inc. is a urologic oncology company. It is engaged in developing technologies to better visualize and treat urologic cancers through minimally invasive surgery, including bladder and prostate cancer. Its first product, enCAGE Coil, is designed to eliminate the limitations of other methods of prostate cancer treatment that can cause erectile dysfunction and urinary incontinence. The device is a disposable, focal therapy, precision ablation system that will deliver bipolar, radio frequency energy through a distinctive coil electrode, or cage. It enables the surgeon to preset margins for precise tissue targeting. Its second product, the i/Blue Imaging System, will bring several key technological advancements that improve the utility of blue light imaging for visualizing bladder cancer. The i/Blue System delivers blue light imaging technology in a more versatile, practical, and accessible format and is designed to work with existing fiberoptic endoscopes on the market.


CSE:IME - Post by User

Bullboard Posts
Comment by Papertiger73on Jun 03, 2019 12:24pm
103 Views
Post# 29794240

RE:IME Key Date

RE:IME Key Date They are really streching out the reporting for a do nothing quarter that ended in March.

It only took them 8 weeks to get the results out for the 1st quarter, now it is taking them 10 weeks to put out Q2.

This leads me to believe that either:

A) Bad results on the way, so they are pushing it off as far as they can

B) Trying to negotiate a deal/awaiting news from FDA

Hoping it is the latter, but would imagine it is the former.

I am far from the shallows now.

Cause I am in too deep, and I am trying to keep my Up above in my head, instead of going under (too late for that)
Bullboard Posts